Vedolizumab bei Colitis ulcerosa und Morbus Crohn: eine Standortbestimmung

Title
Vedolizumab bei Colitis ulcerosa und Morbus Crohn: eine Standortbestimmung
Authors
Keywords
-
Journal
ZEITSCHRIFT FUR GASTROENTEROLOGIE
Volume 53, Issue 06, Pages 591-602
Publisher
Georg Thieme Verlag KG
Online
2015-05-28
DOI
10.1055/s-0034-1399400

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started